Filter
716
Text search:
drug
dosing
Featured
Recommendations
102
New Publications
195
Language
Document type
No document type
418
Guidelines
153
Studies & Reports
76
Manuals
24
Training Material
15
Fact sheets
13
Strategic & Response Plan
10
Situation Updates
3
Resource Platforms
2
App
1
Online Courses
1
Countries / Regions
India
45
South Africa
33
Kenya
23
Tanzania
21
Ethiopia
17
Global
15
Zambia
14
Uganda
10
Nepal
10
Africa
10
Rwanda
9
Ghana
8
Namibia
8
Sierra Leone
7
Nigeria
7
Malawi
7
Western and Central Europe
7
Zimbabwe
6
Bangladesh
6
Myanmar / Burma
6
Philippines
5
Liberia
4
USA
4
Cambodia
4
South Sudan
3
Eswatini/ Swaziland
3
Lesotho
3
Latin America and the Carribbean
3
Congo, Democratic Republic of
2
Syria
2
Argentina
2
Ukraine
2
West and Central Africa
2
South–East Asia Region
2
Eastern Europe and Central Asia
2
Asia
2
Burkina Faso
1
Cameroon
1
Haiti
1
Pakistan
1
Iraq
1
Germany
1
Gambia
1
Indonesia
1
Sudan
1
Benin
1
Brazil
1
Botswana
1
Angola
1
East and Southern Africa
1
Venezuela
1
Eastern Europe
1
Albania
1
Canada
1
Tajikistan
1
Russia
1
Georgia
1
North America
1
Spain
1
Authors & Publishers
Publication Years
Category
Countries
242
Clinical Guidelines
146
Women & Child Health
40
Public Health
24
Capacity Building
20
Key Resources
3
Pharmacy & Technologies
3
Annual Report MEDBOX
1
Toolboxes
HIV
108
TB
85
AMR
62
Pharmacy
34
Mental Health
32
COVID-19
24
NCDs
20
NTDs
17
Caregiver
11
Ebola
8
Conflict
6
Rapid Response
5
Refugee
5
Cholera
4
Planetary Health
3
Polio
2
Specific Hazards
2
Health Financing Toolbox
2
Disability
1
Updated recommendations on treatment of adolescents and children with chronic HCV infection
recommended
The new treatment recommendations that extend the 2018 treat all recommendation for adults with chronic HCV infection to include adolescents and children down to 3 years, and to align the existing recommended pangenotypic direct-acting antiviral (DAA) regimens (SOF/DCV, SOF/VEL and G/P) for adults,
...
The pandemic has emphasized the high risk of avoidable harm to patients, health workers, and the general public, and has identified a range of safety gaps across all core components of health systems at all levels.
The rapid review ‘Implications of the COVID-19 pandemic for patient safety’ ex
...
Ukrainian Title:
УКРАЇНА: Еквівалентність лікарських засобів, зареєстрованих в Україні та інших країнах. Інформація для працівників охорони здоров'я та пацієнтів
To support t
...
Resumen para Equipos de Salud Edición 2021-2022
Las presentes recomendaciones se encuentran dirigidas a los miembros del equipo de salud que asisten niñas, niños y adolescentes (NNyA) que viven con VIH. También se dirigen a los responsables jurisdiccionales que participan en el proceso de gesti
...
Therapeutics for Ebola virus disease
recommended
The WHO Ebola Virus Disease (EVD) Clinical management: living guidance contains the Organization’s most up-to-date recommendations for the clinical management of people with EVD. Providing guidance that is comprehensive and holistic for the optimal care of patients with EVD throughout their il
...
These guidelines provide updated evidence-based recommendations on the priority HCV-related topics from the 2018 WHO Guidelines for the care and treatment of persons diagnosed with chronic hepatitis C infection and the 2017 WHO Guidelines on hepatitis B and C testing. These priority areas are:
...
Recommendations on the initiation and continuing use of nine common types of contraceptive methods are covered by the tool. In addition to looking at individual medical conditions or characteristics, users may also easily combine multiple conditions or characteristics and view the guidance on each c
...
This document outlines the working structure and guiding principles for collaboration of COVAX, the Vaccines pillar of the Access to COVID-19 Tools Accelerator (ACT-A). The working structure of COVAX continues to adapt to emerging needs and the changing trajectory of the pandemic. Some components of
...
The indicators and questions in this document are designed for use by national AIDS programmes and partners to assess the state of a country’s HIV and AIDS response, and to measure progress towards achieving national HIV targets. Countries are encouraged to integrate these indicators and questions
...
PLoS Neglected Tropical diseases August 16, 2021 https://doi.org/10.1371/journal.pntd.0009697
Chagas disease, also known as American trypanosomiasis, is a neglected tropical disease transmitted by triatomine insects, first identified in 1909. Chagas disease affects approximately 6–7 million peop
...
This document focuses on the management of patients affected by gambiense HAT and
constitutes an update to the WHO therapeutic guidance issued in 2013. The main changes in recommendations concern the criteria and methods for deciding the treatment among the new set of therapeutic options and the pa
...
Since 2000, concerted efforts by national programmes, supported by public–private partnerships, nongovernmental organizations, donors and academia under the auspices and coordination of the World Health Organization (WHO), have produced important achievements in the control of human African trypan
...
PLoS Negl Trop Dis 15(8): e0009697. Chagas disease (CD), caused by the parasite Trypanosoma cruzi, affects ~6–7 million people worldwide. Significant limitations still exist in our understanding of CD. Harnessing individual participant data (IPD) from studies could support more in-depth analyses t
...
The purpose of this guide is to provide practical advice for health staff undertaking infectious disease preparedness and response activities to ensure that access to safe abortion care (SAC) is maintained when an infectious disease outbreak occurs. It is an operational guide which can serve to supp
...
The annual Joint Meeting of the Food and Agriculture Organization of the United Nations (FAO) Panel of Experts on Pesticide Residues in Food and the Environment and the World Health Organization (WHO) Core Assessment Group on Pesticide Residues (JMPR) was held in Rome, Italy, from 13 to 22 September
...
World Health Organization. (2021). Minimum technical standards and recommendations for reproductive, maternal, newborn and child health care for emergency medical teams. World Health Organization.
This publication describes the first WHO public-benefit Target Product Profiles (TPPs) for snakebite antivenoms. It focuses on antivenoms for treatment of snakebite envenoming in sub-Saharan Africa. Four TPPs are described in the document:
Broad spectrum Pan-African polyvalent antivenoms: products
...
Background: Atherosclerotic cardiovascular diseases (ASCVD) including myocardial infarction, stroke and peripheral arterial disease continue to be major causes of premature death, disability and healthcare expenditure globally. Preventing the accumulation of cholesterol-containing atherogenic lipopr
...
In 2012, all Member States of the World Health Organization (WHO) endorsed a historical target to reduce premature mortality from noncommunicable diseases
(NCD). This commitment was echoed in 2015 by the United Nations Sustainable Development Goals, which included a target to reduce premature morta
...
The World Heart Federation (WHF) commenced a Roadmap initiative in 2015 to reduce the global burden of cardiovascular disease and resultant burgeoning of healthcare costs. Roadmaps provide a blueprint for implementation of priority solutions for the principal cardiovascular diseases leading to death
...
